98%
921
2 minutes
20
Introduction: Chickenpox (varicella) contributes to a large number of hospitalisations in the United Kingdom (UK) where vaccination is not routine, and can result in serious complications. The varicella vaccine was recommended for inclusion in the UK routine immunisation schedule by the Joint Committee on Vaccination and Immunisation (JCVI) in November 2023. A systematic review identified no previous qualitative studies investigating UK parents' views regarding chickenpox and vaccination.
Objective: To explore parents' views of chickenpox and varicella vaccination, and identify barriers and facilitators to this and other childhood vaccinations.
Methods: Underpinned by sequential mixed-methodology a quantitative cross-sectional online survey (n = 609), distributed via nurseries and social media, and qualitative semi-structured interviews (n = 12) with a sub-sample of survey respondents. Descriptive statistical analysis was undertaken on quantitative data. Qualitative data were interpreted by reflexive thematic analysis, according to the EQUATOR network standards for reporting qualitative research. Findings were analysed separately, and integrated equally using a triangulation protocol for validation or repudiation.
Findings: Integration demonstrated parents perceived chickenpox as a common, typically mild, childhood illness. Parents held few concerns, with most worries focussing on severe infection risk, and impact on time off school or work. Most would accept routine varicella vaccination, though had concerns about duration of immunity. Many questioned necessity of vaccination, and whether natural immunity was superior. Non-vaccinating parents hold distinct concerns relating to safety, vaccine contents, and their synthetic nature.
Discussion And Conclusion: Whilst most parents are accepting of vaccination, they hold specific concerns related to varicella vaccination which may result in sub-optimal uptake for critical herd immunity. To achieve this it will be crucial to raise awareness of the potential risks of chickenpox, and address concerns identified. Many parents seek reliable vaccine information from healthcare professionals, and so appropriate education and training should be considered, including communicating risks and benefits of vaccination, which may be beneficial antenatally.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.vaccine.2025.127322 | DOI Listing |
Medicine (Baltimore)
September 2025
Family and Community Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
Herpes zoster (HZ) is a reactivation of the varicella-zoster virus. It is a common infection, especially among patients with diabetes mellitus (DM). This study aimed to assess the awareness and uptake of the HZ vaccine, as well as their determinants, among patients with diabetes DM in the Aseer Region, Saudi Arabia.
View Article and Find Full Text PDFVaccine
September 2025
Department of Paediatric Immunology and Rheumatology, Wilhelmina Children's Hospital/ University Medical Center Utrecht, Utrecht, the Netherlands; Faculty of Medicine, Utrecht University, Utrecht, the Netherlands.
Background: Pediatric patients with autoimmune and inflammatory diseases often require immunosuppressive therapy, which increases their susceptibility to infections, including varicella-zoster virus (VZV). While the live attenuated varicella vaccine is contraindicated in most immunocompromised children, the recombinant subunit vaccine, Shingrix, may offer an alternative preventive strategy. However, data on its safety, immunogenicity, and efficacy in pediatric VZV-naïve patients remain limited.
View Article and Find Full Text PDFLancet Rheumatol
September 2025
Service de Médecine interne et polyvalente, Centre Hospitalier du Haut-Anjou, Château-Gontier, France; Université d'Angers, Inserm, CNRS, MITOVASC, Equipe MitoLab, SFR ICAT, F-49000 Angers, France. Electronic address:
Infections are increasingly recognised as a major cause of morbidity and mortality in patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. We conducted a systematic review to characterise the infectious burden of VEXAS syndrome and propose preventive strategies. We included 57 studies (813 patients) showing that infections in patients with VEXAS syndrome were frequent, severe in 40-60% of cases, and fatal in 6-15% of cases.
View Article and Find Full Text PDFEnviron Pollut
September 2025
Guangdong-Hong Kong-Macao Joint Laboratory for Contaminants Exposure and Health, Guangzhou Center for Disease Control and Prevention, Guangzhou, 510440, China; School of Public Health, Southern Medical University, Guangzhou, 510515, China. Electronic address:
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants that are widely detected in human serum worldwide, and are associated with reduced vaccine-induced antibody responses. However, existing research has primarily focused on the effects of prenatal and adolescent PFAS exposures on antibody levels or disease incidence. A critical gap remains in understanding the association between serum PFAS concentrations and antibody levels in children.
View Article and Find Full Text PDFEuro Surveill
September 2025
Welfare Epidemiology and Monitoring Unit, Department of Public Health, Finnish Institute for Health and Welfare, Helsinki, Finland.
BACKGROUNDHerpes zoster, also known as shingles, is a painful skin condition caused by varicella zoster virus. Information is lacking on incidence of herpes zoster in Finland.AIMTo estimate age-specific annual incidence of herpes zoster over 9 years with data from several nationwide health registers.
View Article and Find Full Text PDF